Bioversys AG (BIOV) — Financial Flexibility Index
Bioversys AG (BIOV) has a Financial Flexibility Index of -0.70x as of December 2025. Free cash flow of CHF-21.73 Million (operating CF CHF-21.95 Million minus capex CHF216.00K) represents -1% of total liabilities (CHF30.82 Million). Check BIOV asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bioversys AG Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for Bioversys AG across 2 annual periods. See how liquid is Bioversys AG's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Bioversys AG (2024–2025)
Year-by-year free cash flow to debt coverage for Bioversys AG. For the full company profile including market capitalisation, see BIOV market cap overview.
| Year | Flexibility Index | Free Cash Flow (CHF) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.70x | CHF-21.73 Million | CHF-21.95 Million | CHF30.82 Million | ▼ -10.1% |
| 2024 | -0.64x | CHF-15.54 Million | CHF-15.57 Million | CHF24.27 Million | — |